PRECIGEN, INC. Earnings Per Share, Basic and Diluted
PRECIGEN, INC. (PGEN) reported Earnings Per Share, Basic and Diluted of -$0.23 per share for the 3-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-03-01
- PRECIGEN, INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.23.
- PRECIGEN, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.18.
- PRECIGEN, INC. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.26.
- PRECIGEN, INC. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.35.
- PRECIGEN, INC. earnings per share, basic and diluted for fiscal 2020 was -$1.02.
- PRECIGEN, INC. earnings per share, basic and diluted for fiscal 2019 was -$2.09.
- PRECIGEN, INC. earnings per share, basic and diluted for fiscal 2018 was -$3.93.
- PRECIGEN, INC. earnings per share, basic and diluted for fiscal 2017 was -$0.98.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | -$0.23 10-K · filed 2021-03-01 | -$1.02 10-K · filed 2021-03-01 | |||
| 2020-09-30 | -$0.18 10-K · filed 2021-03-01 | -$0.79 10-Q · filed 2020-11-09 | |||
| 2020-06-30 | -$0.26 10-K · filed 2021-03-01 | -$0.61 10-Q · filed 2020-08-10 | |||
| 2020-03-31 | -$0.35 10-K · filed 2021-03-01 | ||||
| 2019-12-31 | -$1.09 10-K · filed 2021-03-01 | -$2.09 10-K · filed 2021-03-01 | |||
| 2019-09-30 | -$0.35 10-K · filed 2021-03-01 | -$1.00 10-Q · filed 2020-11-09 | |||
| 2019-06-30 | -$0.25 10-K · filed 2021-03-01 | -$0.65 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | -$0.40 10-K · filed 2021-03-01 | ||||
| 2018-12-31 | -$2.59 10-K · filed 2020-03-02 | -$3.93 10-K · filed 2021-03-01 | |||
| 2018-09-30 | -$0.44 10-K · filed 2020-03-02 | -$1.31 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | -$0.51 10-K · filed 2020-03-02 | -$0.87 10-Q · filed 2019-08-09 | |||
| 2018-03-31 | -$0.36 10-K · filed 2020-03-02 | -$0.33 10-Q · filed 2018-05-10 | |||
| 2017-12-31 | -$0.23 10-K · filed 2019-03-01 | -$0.98 10-K · filed 2020-03-02 | |||
| 2017-09-30 | -$0.33 10-K · filed 2019-03-01 | -$0.75 10-Q · filed 2018-11-08 | |||
| 2017-06-30 | -$0.16 10-K · filed 2019-03-01 | -$0.42 10-Q · filed 2018-08-13 | |||
| 2017-03-31 | -$0.26 10-K · filed 2019-03-01 | ||||
| 2016-12-31 | -$0.37 10-K · filed 2018-03-01 | -$1.58 10-K · filed 2019-03-01 | |||
| 2016-09-30 | -$0.24 10-K · filed 2018-03-01 | -$1.21 10-Q · filed 2017-11-09 | |||
| 2016-06-30 | -$0.42 10-K · filed 2018-03-01 | -$0.97 10-Q · filed 2017-08-09 | |||
| 2016-03-31 | -$0.55 10-K · filed 2018-03-01 | ||||
| 2015-12-31 | -$0.76 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | -$0.34 10-Q · filed 2016-11-09 | -$0.47 10-Q · filed 2016-11-09 | |||
| 2015-06-30 | -$0.37 10-Q · filed 2016-08-09 | -$0.13 10-Q · filed 2016-08-09 | |||
| 2014-12-31 | $0.19 derived: net income ÷ weighted average shares · filed 2017-03-01 | -$0.34 derived: net income ÷ weighted average shares · filed 2017-03-01 | -$0.86 derived: net income ÷ weighted average shares · filed 2017-03-01 | -$0.83 10-K · filed 2017-03-01 | |
| 2014-09-30 | -$0.53 10-Q · filed 2015-11-09 | -$1.05 derived: net income ÷ weighted average shares · filed 2015-11-09 | -$1.02 10-Q · filed 2015-11-09 | ||
| 2014-06-30 | -$0.53 10-Q · filed 2015-08-10 | -$0.49 10-Q · filed 2015-08-10 | |||
| 2013-12-31 | -$1.40 10-K · filed 2016-02-29 | ||||
| 2013-06-30 | -$2.45 10-Q · filed 2014-08-14 | -$2.46 10-Q/A · filed 2013-10-21 | -$10.00 10-Q · filed 2014-08-14 | ||
| 2012-12-31 | -$6.52 10-K · filed 2014-03-31 | -$18.77 10-K · filed 2015-03-02 | |||
| 2012-09-30 | -$4.66 10-K · filed 2014-03-31 | ||||
| 2012-06-30 | -$3.99 10-K · filed 2014-03-31 | -$7.54 10-Q/A · filed 2013-10-21 | |||
| 2012-03-31 | -$3.55 10-K · filed 2014-03-31 | ||||
| 2011-12-31 | -$18.92 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |